1Globe

1Globe Health Institute is a private biotechnology company and research organization headquartered in Cambridge, Massachusetts. The company focuses on the discovery and development of novel therapeutics across oncology, inflammation, and infectious diseases. It operates as a global innovation hub, often collaborating with academic institutions and other biotech firms to advance early-stage research into clinical applications. 1Globe is also known for its strategic investments and involvement in the management of various life science entities globally. The institute's lead programs include small molecule modulators of the immune system, specifically targeting Toll-like receptors for cancer immunotherapy.